Company Divi's Laboratories Limited

Equities

DIVISLAB

INE361B01024

Pharmaceuticals

Delayed NSE India S.E. 08:01:59 2024-03-28 am EDT 5-day change 1st Jan Change
3,445 INR +2.30% Intraday chart for Divi's Laboratories Limited -0.58% -11.75%

Business Summary

Divi's Laboratories Limited is specialized in the development and manufacture of active pharmaceutical ingredients, intermediates and nutraceutical ingredients.

Net sales by source of revenue break down into product sales (97.9%) and service sales (2.1%).

At the end of March 2020, the group has 2 production sites located in India.

Number of employees: 8,433

Sales per Business

INR in Million2022Weight2023Weight Delta
Active Pharmaceutical Ingredients and Intermediates
100.0 %
89,598 100.0 % 77,675 100.0 % -13.31%

Sales per region

INR in Million2022Weight2023Weight Delta
Europe
41.0 %
28,801 32.1 % 31,873 41.0 % +10.66%
United States
23.8 %
20,047 22.4 % 18,466 23.8 % -7.89%
Asia
13.4 %
7,981 8.9 % 10,412 13.4 % +30.47%
India
12.6 %
10,378 11.6 % 9,756 12.6 % -6.00%
Americas
4.7 %
18,929 21.1 % 3,676 4.7 % -80.58%
Rest of the World
4.5 %
3,462 3.9 % 3,492 4.5 % +0.88%

Managers

Managers TitleAgeSince
Chief Executive Officer 46 01-08-09
Founder 73 90-10-11
Director of Finance/CFO 74 94-11-19
Chief Tech/Sci/R&D Officer 59 90-10-31
Chief Tech/Sci/R&D Officer 58 90-10-31
Chief Administrative Officer 60 94-09-30
Chief Tech/Sci/R&D Officer 71 09-05-19
Compliance Officer - 19-07-18
Director/Board Member 62 Feb. 09
Director/Board Member 42 12-06-30

Members of the board

Members of the board TitleAgeSince
Founder 73 90-10-11
Chief Executive Officer 46 01-08-09
Director/Board Member - 14-06-22
Director/Board Member 66 94-12-25
Director/Board Member 42 12-06-30
Director/Board Member 62 Feb. 09
Chairman - 17-06-26
Director/Board Member 71 17-07-21
Director/Board Member 68 19-03-27
Director/Board Member 69 20-01-03

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 265,468,580 126,589,760 ( 47.69 %) 0 47.69 %

Shareholders

NameEquities%Valuation
54,000,000 20.34 % 2 272 M ₹
54,000,000 20.34 % 2 272 M ₹
SBI Funds Management Ltd.
7.944 %
21,089,555 7.944 % 887 M ₹
Life Insurance Corporation of India (Investment Portfolio)
5.696 %
15,121,752 5.696 % 636 M ₹
14,000,000 5.274 % 589 M ₹
Divis Biotech Pvt Ltd.
3.014 %
8,000,000 3.014 % 337 M ₹
7,567,000 2.850 % 318 M ₹
Axis Asset Management Co. Ltd.
2.122 %
5,633,360 2.122 % 237 M ₹
UTI Asset Management Co. Ltd. (Investment Management)
1.244 %
3,302,993 1.244 % 139 M ₹
Norges Bank Investment Management
1.208 %
3,206,823 1.208 % 135 M ₹

Company contact information

Divi's Laboratories Ltd.

Divi Towers Cyber Hills, Gachibowli

500032, Hyderabad

+91 40 6696 6300

http://www.divislabs.com
address Divi's Laboratories Limited(DIVISLAB)

Sales per region

Trading Rating
Investor Rating
ESG Refinitiv
B
More Ratings
Sell
Consensus
Buy
Mean consensus
UNDERPERFORM
Number of Analysts
23
Last Close Price
3,445 INR
Average target price
3,415 INR
Spread / Average Target
-0.89%
Consensus